1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Editas Medicine Inc (EDIT) Files 10-K for the Fiscal Year Ended on December 31, 2017

March 08, 2018 | About:

Editas Medicine Inc (NASDAQ:EDIT) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. Editas Medicine Inc has a market cap of $1.94 billion; its shares were traded at around $42.81 with and P/S ratio of 157.40.

For the last quarter Editas Medicine Inc reported a revenue of $3.67 million, compared with the revenue of $0.90 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $13.7 million, an increase of 126.8% from last year.

The reported loss per diluted share was $2.98 for the year, compared with the loss per share of $0 in the previous year. The Editas Medicine Inc had an operating margin of -873.64%, compared with the operating margin of -1605.62% a year before. The 10-year historical median operating margin of Editas Medicine Inc is -1886.67%. The profitability rank of the company is 4 (out of 10).

At the current stock price of $42.81, Editas Medicine Inc is traded at 52.5% premium to its historical median P/S valuation band of $28.08. The P/S ratio of the stock is 157.40, while the historical median P/S ratio is 103.24. The stock gained 98.68% during the past 12 months.

CEO Recent Trades:

  • President and CEO Katrine Bosley sold 8,333 shares of EDIT stock on 03/01/2018 at the average price of $35.72. The price of the stock has increased by 19.85% since.

CFO Recent Trades:

  • CFO Andrew A. F. Hack sold 18,000 shares of EDIT stock on 02/16/2018 at the average price of $34.21. The price of the stock has increased by 25.14% since.

For the complete 20-year historical financial data of EDIT, click here.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


louis16120031 Yr Momentum
flyflipperKW DCF 25+%
itflpalmsBRUCE Book
itflpalmsTest4
DBrizanall 2018Oct20 233a
DBrizanall 2018Oct20 1212a
meric99999Share Buyback
sunnywhylonecapital
pbarker46Stock yield near hist. high
louis1612003SP600 ROC
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK